This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Stem Cell Research & Therapy Open Access 18 September 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Sheridan, C. First off-the-shelf mesenchymal stem cell therapy nears European approval. Nat Biotechnol 36, 212–214 (2018). https://doi.org/10.1038/nbt0318-212a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0318-212a
This article is cited by
-
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Stem Cell Research & Therapy (2020)
-
The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage
Stem Cell Reviews and Reports (2019)
-
Biological functions of mesenchymal stem cells and clinical implications
Cellular and Molecular Life Sciences (2019)